載入中
NASDAQFinancial ServicesAsset Management - Cryptocurrency
最新資料
US$3.40
+US$0.035 · +1.04%
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
前收盤價
US$3.40
+US$0.035 · +1.04%
盤中時間採用ET。市場資料可能有所延遲。
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
日內區間
目前US$3.40
52週區間
目前US$3.40
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
51
合理估值
情緒
46
多空交錯
風險
82
極高風險
動能
20
強勢下行
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
日內區間
目前US$3.40
52週區間
目前US$3.40
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 81.35萬 USD | 5.73萬 USD | 3787 USD | — | 1400萬 USD |
| 銷貨成本 | 30.33萬 USD | 392.72萬 USD | 1.6萬 USD | — | 160萬 USD |
| 毛利 | 51.02萬 USD | −386.99萬 USD | −1.22萬 USD | — | 1240萬 USD |
| 研究與開發 | 191.04萬 USD | 1446.27萬 USD | 1297.58萬 USD | 1337.87萬 USD | 1485.09萬 USD |
| 銷售、一般及管理費用 | 1717.57萬 USD | 1433.31萬 USD | 1241.84萬 USD | 1452.69萬 USD | 1056.97萬 USD |
| 營業費用 | 1949.15萬 USD | 4486.83萬 USD | 2539.42萬 USD | 2691.15萬 USD | 2542.05萬 USD |
| 利息收入 | 24萬 USD | 25.4萬 USD | 69.36萬 USD | 8.33萬 USD | 2516 USD |
| 利息支出 | 155.78萬 USD | 248.44萬 USD | 237.19萬 USD | 138.01萬 USD | 38.78萬 USD |
| 折舊和攤銷 | — | 112.84萬 USD | 78.32萬 USD | 30.74萬 USD | 22.16萬 USD |
| 營業利益 | −1898.13萬 USD | −4873.82萬 USD | −2540.64萬 USD | −2691.15萬 USD | −1302.05萬 USD |
| 淨利 | −4531.44萬 USD | −4981.84萬 USD | −2726.11萬 USD | −2801.12萬 USD | −1277.84萬 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
